Endometriosis is associated with aberrant metabolite profiles in plasma
A diagnostic model based on acylcarnitines can predict the presence and stage of endometriosis.
Volume 107, Issue 3, Pages 699–706
Authors:
Sophia Letsiou, Ph.D., Dirkje P. Peterse, M.Sc., Amelie Fassbender, Ph.D., Margriet M. Hendriks, Ph.D., Niels J. van den Broek, B.Sc., Rudolf Berger, M.D., Dorien F. O, M.Sc., Arne Vanhie, M.D., Alexandra Vodolazkaia, M.D., Ph.D., Anne Van Langendonckt, M.D., Ph.D., Jacques Donnez, M.D., Ph.D., Amy C. Harms, Ph.D., Rob J. Vreeken, Ph.D., Patrick G. Groothuis, Ph.D., Marie-Madeleine Dolmans, M.D., Ph.D., Arjan B. Brenkman, Ph.D., Thomas M. D'Hooghe, M.D., Ph.D.
Abstract:
A diagnostic model based on acylcarnitines has the potential to predict the presence and stage of endometriosis.
No comments yet.